Ocular Therapeutix, Inc.

Rachunek Zysków i Strat


Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna



Przychody TTM (mln): 61
EBIT TTM (mln): -160
index 0 1 2 3 4 5 6 7 8 9 10 11 12
Rok finansowy 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 0 0 1 2 2 2 2 4 17 44 51 58 64
Przychód Δ r/r 0.0% -100.0% inf% 126.7% 7.8% 1.9% 3.5% 112.4% 311.7% 150.1% 18.3% 13.5% 9.0%
Marża brutto 30.0% 0.0% 88.2% 81.8% 76.5% 76.2% 76.6% 45.0% 88.0% 89.9% 91.2% 91.0% 91.2%
EBIT (mln) -14 -13 -27 -38 -43 -62 -59 -86 -63 -78 -79 -82 -172
EBIT Δ r/r 0.0% -5.6% 110.0% 41.0% 13.4% 42.9% -4.5% 45.1% -26.8% 24.2% 0.8% 4.7% 108.5%
EBIT (%) -136710.0% 0.0% -3509.6% -2182.7% -2296.0% -3220.1% -2970.8% -2029.9% -361.1% -179.3% -152.7% -141.0% -269.6%
Koszty finansowe (mln) 0 0 1 2 2 2 2 6 7 7 7 11 14
EBITDA (mln) -13 -12 -28 -38 -43 -61 -58 -85 -63 -78 -78 -79 -176
EBITDA(%) -133120.0% 0.0% -3565.9% -2172.8% -2280.0% -3197.8% -2926.6% -2001.0% -360.2% -179.2% -151.2% -135.9% -276.4%
Podatek (mln) 0 0 0 1 1 0 -2 4 4 4 -8 0 0
Zysk Netto (mln) -14 -13 -29 -40 -45 -63 -58 -90 -160 -11 -63 -81 -194
Zysk netto Δ r/r 0.0% -5.5% 115.1% 38.7% 12.5% 41.8% -9.0% 55.9% 77.5% -93.2% 487.0% 27.3% 139.7%
Zysk netto (%) -140930.0% 0.0% -3710.9% -2271.3% -2369.0% -3296.2% -2899.1% -2127.6% -917.3% -24.8% -123.2% -138.1% -303.7%
EPS -4.77 -4.51 -2.69 -1.71 -1.8 -2.2 -1.51 -1.99 -2.63 -0.14 -0.83 -1.01 -1.22
EPS (rozwodnione) -4.77 -4.51 -2.69 -1.71 -1.8 -2.2 -1.51 -1.99 -2.63 -0.13 -0.83 -0.94 -1.22
Ilośc akcji (mln) 3 3 11 23 25 29 38 45 61 76 77 80 158
Ważona ilośc akcji (mln) 3 3 11 23 25 29 38 45 61 82 77 86 158
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD